← Leaderboards
Deanna L Kelly
University Of Maryland Baltimore
$13,077,948
Attributed
$17,105,948
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,105,948 · 12
By mechanism
R01$11,247,049 · 5
R37$3,078,526 · 1
R56$740,923 · 1
R34$712,305 · 1
T32$616,145 · 1
R21$412,500 · 1
Top collaborators
- William W Eaton9 shared
- William T. Carpenter5 shared
- Gregory I Elmer5 shared
- Reza Ghodssi2 shared
- Seth S Himelhoch2 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Alessio Fasano$18,889,816
- Debra R Counts$295,220
- Kristina Michelle Harris$153,500
- Rebecca G. Nowak$3,906,171
- Sylvia Adebajo$2,792,614
Others in their field
Top investigators on “Schizophrenia”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,668,216
- Raquel E Gur · University Of Pennsylvania$60,189,770
- Mark J Daly · Broad Institute, Inc.$48,989,393
- John M Kane · Long Island Jewish Medical Center$45,235,871
- Carrie E Bearden · University Of California Los Angeles$42,025,230
- Scott W Woods · Yale University$41,221,536
Research focus
SchizophreniaPharmaceutical PreparationsRandomizedReportingClozapinePersonsAntipsychotic AgentsSymptomsAreaInterestLinkFunctional DisorderClinical TrialsSafetyOutpatientsParticipantMonitorFuturePlacebosPathway InteractionsDouble-Blind MethodResistanceBiological MarkersMediating
Grant awards (43)
Multidisciplinary Schizophrenia Research Training$216,097
T32 · FY2025 · MH
4/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial$193,125
R01 · FY2025 · MH · contact PI
Multidisciplinary Schizophrenia Research Training$227,617
T32 · FY2024 · MH
4/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial$193,125
R01 · FY2024 · MH · contact PI
A Randomized Controlled Trial of a Telementoring Program, Project ECHO, to increase Clozapine Prescribing$769,293
R37 · FY2023 · MH · contact PI
4/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial$193,125
R01 · FY2023 · MH · contact PI
Multidisciplinary Schizophrenia Research Training$111,525
T32 · FY2023 · MH
A Randomized Controlled Trial of a Telementoring Program, Project ECHO, to increase Clozapine Prescribing$765,406
R37 · FY2022 · MH · contact PI
4/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial$193,125
R01 · FY2022 · MH · contact PI
Multidisciplinary Schizophrenia Research Training$40,151
T32 · FY2022 · MH
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies$773,272
R01 · FY2021 · MH · contact PI
A Randomized Controlled Trial of a Telementoring Program, Project ECHO, to increase Clozapine Prescribing$770,247
R37 · FY2021 · MH · contact PI
4/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial$193,125
R01 · FY2021 · MH · contact PI
Multidisciplinary Schizophrenia Research Training$20,755
T32 · FY2021 · MH
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies$955,279
R01 · FY2020 · MH · contact PI
A Randomized Controlled Trial of a Telementoring Program, Project ECHO, to increase Clozapine Prescribing$773,580
R37 · FY2020 · MH · contact PI
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies$211,977
R01 · FY2020 · MH · contact PI
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies$780,579
R01 · FY2019 · MH · contact PI
Optimizing Smoking Cessation Treatments in Smokers Living with HIV/AIDS$700,288
R01 · FY2019 · HL
Biomarker and Safety Study of Clozapine in Benign Ethnic Neutropenia$839,235
R01 · FY2018 · MH · contact PI
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies$783,201
R01 · FY2018 · MH · contact PI
Optimizing Smoking Cessation Treatments in Smokers Living with HIV/AIDS$775,619
R01 · FY2018 · HL
Biomarker and Safety Study of Clozapine in Benign Ethnic Neutropenia$39,418
R01 · FY2018 · MH · contact PI
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies$801,031
R01 · FY2017 · MH · contact PI
Biomarker and Safety Study of Clozapine in Benign Ethnic Neutropenia$799,875
R01 · FY2017 · MH · contact PI
Biomarker and Safety Study of Clozapine in Benign Ethnic Neutropenia$799,852
R01 · FY2016 · MH · contact PI
Microsystem Development for Clozapine Monitoring in Schizophrenia$363,774
R56 · FY2016 · MH · contact PI
Biomarker and Safety Study of Clozapine in Benign Ethnic Neutropenia$46,603
R01 · FY2016 · MH · contact PI
Biomarker and Safety Study of Clozapine in Benign Ethnic Neutropenia$912,975
R01 · FY2015 · MH · contact PI
Microsystem Development for Clozapine Monitoring in Schizophrenia$377,149
R56 · FY2015 · MH · contact PI
Development for RCT of Gluten Free Diet in Gliadin-Positive Schizophrenia$193,532
R34 · FY2015 · MH
Adjunct Aripiprazole for Symptomatic Hyperprolactinemia in Female Schizophrenia$307,000
R01 · FY2014 · MH · contact PI
Development for RCT of Gluten Free Diet in Gliadin-Positive Schizophrenia$235,886
R34 · FY2014 · MH
Adjunct Aripiprazole for Symptomatic Hyperprolactinemia in Female Schizophrenia$294,720
R01 · FY2013 · MH · contact PI
Development for RCT of Gluten Free Diet in Gliadin-Positive Schizophrenia$282,887
R34 · FY2013 · MH
Adjunct Aripiprazole for Symptomatic Hyperprolactinemia in Female Schizophrenia$307,000
R01 · FY2012 · MH · contact PI
Adjunctive Minocycline in Clozapine Treated Patients for Psychosis and Cognition$187,500
R21 · FY2012 · MH · contact PI
Adjunctive Minocycline in Clozapine Treated Patients for Psychosis and Cognition$225,000
R21 · FY2011 · MH · contact PI
Adjunct Aripiprazole for Symptomatic Hyperprolactinemia in Female Schizophrenia$153,500
R01 · FY2011 · MH · contact PI
Comorbid Substance Abuse and Long-Term Health Outcomes in Schizophrenia$75,000
R03 · FY2008 · MH · contact PI
Comorbid Substance Abuse and Long-Term Health Outcomes in Schizophrenia$75,000
R03 · FY2007 · MH · contact PI
Cardiac-Related Mortality with Atypical Antipsychotics$74,250
R03 · FY2005 · MH
Cardiac-Related Mortality with Atypical Antipsychotics$74,250
R03 · FY2004 · MH